After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Get the (MBRX) Report Here
Trade with Jim Cramer 14 Days FREE
These under -$10 stocks are poised to breakout and trade higher from current levels.
Here's the lowdown on the biotech companies that have come public this year.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that
it has completed the acquisition of Metabasis Therapeutics, Inc.
Several small-cap stocks were poised to move on above-average volume during Tuesday's session.
Several small-cap stocks were moving on above-average volume during Thursday's session.
Capstone Turbine shares jumped on a big order.
Accentia climbs on SinuNase study results.
The stock rises on unusual volume as news of an acquisition emerges.
Cortex Pharma climbs on greenlight from the FDA for an Alzheimer's trial.
Shares slump on disappointing results for type 2 diabetes candidate CS-917.
They sign a deal with Schering-Plough.
Both companies will offer drug candidates to the venture.
Metabasis Therapeutics falls after halting two diabetes trials.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.